Generic name:antihemophilic factor (recombinant), glycopegylated-exel
Dosage form: injection
Drug class:Miscellaneous coagulation modifiers
Medically reviewed by Drugs.com. Last updated on Sep 21, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Esperoct
Esperoct [antihemophilic factor (recombinant), glycopegylated-exei] is a recombinant DNA-derived coagulation Factor VIII concentrate indicated for use in adults and children with hemophilia A for:
- •
- On-demand treatment and control of bleeding episodes
- •
- Perioperative management of bleeding
- •
- Routine prophylaxis to reduce the frequency of bleeding episodes
Limitation of Use:
Esperoct is not indicated for the treatment of von Willebrand disease. (1)
Esperoct Dosage and Administration
For intravenous infusion after reconstitution only.
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram